Fate Therapeutics (FATE) Assets Average (2016 - 2025)
Historic Assets Average for Fate Therapeutics (FATE) over the last 13 years, with Q3 2025 value amounting to $357.7 million.
- Fate Therapeutics' Assets Average fell 3013.17% to $357.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $357.7 million, marking a year-over-year decrease of 3013.17%. This contributed to the annual value of $473.5 million for FY2024, which is 2185.77% down from last year.
- Fate Therapeutics' Assets Average amounted to $357.7 million in Q3 2025, which was down 3013.17% from $385.2 million recorded in Q2 2025.
- In the past 5 years, Fate Therapeutics' Assets Average ranged from a high of $1.0 billion in Q2 2021 and a low of $357.7 million during Q3 2025
- For the 5-year period, Fate Therapeutics' Assets Average averaged around $665.3 million, with its median value being $607.5 million (2023).
- Per our database at Business Quant, Fate Therapeutics' Assets Average skyrocketed by 16730.49% in 2021 and then tumbled by 3013.17% in 2025.
- Quarter analysis of 5 years shows Fate Therapeutics' Assets Average stood at $953.0 million in 2021, then fell by 23.67% to $727.5 million in 2022, then decreased by 27.83% to $525.0 million in 2023, then fell by 10.89% to $467.8 million in 2024, then dropped by 23.55% to $357.7 million in 2025.
- Its Assets Average stands at $357.7 million for Q3 2025, versus $385.2 million for Q2 2025 and $419.7 million for Q1 2025.